Biophysical Society 59th Annual Meeting Program Guide

Name

Disclosure Entity

Disclosure Type

Presentation Number

Bodkin, Michael Borbulevych, Oleg

Evotec (U.K.) Ltd.

Employment (full or part-time) in funding company 1791-Plat

NIH

Research funded by industry grant

3128-Pos

Brown, Arthur Brown, Arthur

ChanTest

Employment (full or part-time) in funding company 2955-Pos

ChanTest Corp.

Non-remunerative positions of influence such as officer, board member, trustee, or public spokesper- son in company

2945-Pos

Bruening-Wright, Andrew

ChanTest Corp.

Employment (full or part-time) in funding company 2945-Pos Ownership or Partnership in funding organization 614-Pos Ownership or Partnership in funding organization 1454-Pos

Bruggemann, Andrea Bruggemann, Andrea

NanionTechnologies NanionTechnologies Oxford Nanopore

Bruhn, Brandon Bruhn, Brandon

Research funded by industry grant Research funded by industry grant

872-Pos 876-Pos

Oxford Nanopores Technologies Ltd

Burke, Tom

CDI

Employment (full or part-time) in funding company 2968-Pos Employment (full or part-time) in funding company 840-Pos

Caffaro, Carolina Candelli, Andrea

Keysight Technologies

LUMICKS

Receipt of royalties from referenced company products

2557-Plat

Cao, Han

BioNano Genomics

Employment (full or part-time) in funding company 742-Pos Employment (full or part-time) in funding company 3014-Pos Employment (full or part-time) in funding company 2968-Pos Employment (full or part-time) in funding company 1893-Pos Employment (full or part-time) in funding company 742-Pos Employment (full or part-time) in funding company 2902-Pos Employment (full or part-time) in funding company 2968-Pos Employment (full or part-time) in funding company 810-Pos

Carlson, Coby Carlson, Coby Casas-Finet, Jose

CDI CDI

MedImmune LLC BioNano Genomics

Chan, Saki

Chapman, Mark

Pfizer, Inc.

Chase, Lucas Chung, Inhee

CDI

Genentech, Incorporated, a member of the Roche Group

Cohen, Charles Corradini, Maria Costantin, James

Xenon Pharmaceuticals

Employment (full or part-time) in funding company 2912-Pos

Pepsi Co.

Research funded by industry grant

3139-Pos

Molecular Devices, LLC

Employment (full or part-time) in funding company 1434-Pos

Covarrubias, Manuel Croquette, Vincent

Autifony Therapeutics Limited Research funded by industry grant

635-Pos 360-Pos

PicoTwist

Non-remunerative positions of influence such as officer, board member, trustee, or public spokesper- son in company

DeLaura, Susan

CDI

Employment (full or part-time) in funding company 2968-Pos Employment (full or part-time) in funding company 742-Pos Employment (full or part-time) in funding company 1243-Pos

Dergachev, Vladimir Dhavala, Sirisha Digman, Michelle Diwu, Zhenjun Dowbenko, Don

BioNano Genomics

Berg LLC

NIH P50-GM076516

Research funded by industry grant

369-Pos

AAT Bioquest

Employment (full or part-time) in funding company 549-Pos Employment (full or part-time) in funding company 810-Pos

Genentech, Incorporated, a member of the Roche Group

Dzakula, Zeljko

BioNano Genomics Oxford Nanopore

Employment (full or part-time) in funding company 742-Pos

Eggenberger, Olivia

Research funded by industry grant

872-Pos

Eisfeld, Jörg Emter, Craig

j.eisfeld@cytocentrics.com Employment (full or part-time) in funding company 2954-Pos

Bristol Myer/AstraZenca

Research funded by industry grant

1462-Pos

Fedorov, Nikolai

ChanTest Microsoft

Employment (full or part-time) in funding company 2955-Pos Employment (full or part-time) in funding company 1833-Plat

Fisher, Jasmin

252

Biophysical Society 59 th Annual Meeting, Baltimore, Maryland

Made with